Developer docs
API playgroundTry for free, no card

Search company profiles

Carclo plc

Full company profile

uuid003eu71

Namestring
Carclo plc
Legal namestring
Carclo plc
Websiteurl
carclo.co.uk
Company typeenum
Public
Founded yearint
1924
Descriptiontext

Carclo plc is a UK-headquartered precision plastics manufacturer serving regulated end-markets across Life Sciences, Aerospace & Defence, and Safety & Security. Founded in 1924 and publicly traded on the London Stock Exchange (LON:CAR), the company specializes in fine-tolerance injection-moulded plastic components where regulatory qualification, traceability, and reliability are non-negotiable. Its Life Sciences segment supplies in vitro diagnostics, medical devices, drug delivery devices, and pharmaceutical packaging; Aerospace & Defence covers aerospace components and mechanical cable solutions; Safety & Security includes ATM secure mechanisms, sensing optics, PPE, and precision gear solutions.

The company operates a platform-plus-products model anchored by two proprietary technology assets: C-Mould, a precision moulding platform enabling validated production at scale, and Syncura, a digital platform for connected medical devices and patient health data. Syncura is being rolled out through a three-part series (launched March–May 2026) covering connected drug delivery, data-to-insight transformation, and an 'IQ vs AI' positioning piece. Production is structured as an end-to-end in-region capability spanning design, tooling, automated qualified manufacturing, and traceability, with facilities in the UK and India.

Carclo generates revenue through B2B contract-based pricing on engineered components, with go-to-market executed via direct enterprise relationships, trade-show presence (MD&M West, Pharmapack, DDL, MSV & Fakuma), and long-tenured customer partnerships averaging 15+ years. FY26 audited results reported revenue of £114.2m (down from £121m) with pre-tax profit of £4.8m; management has executed a 'margin before volume' portfolio simplification, reducing net debt leverage from 2.0x to 1.2x and tracking towards stated targets of 10% Return on Sales and 25% Return on Capital Employed under its Precision 2030 growth plan.

Short descriptiontext

Carclo plc is a UK-based precision plastics manufacturer supplying fine-tolerance injection-moulded components for regulated markets including life sciences (IVD, drug delivery, pharma packaging), aerospace and defence, and safety and security applications, operated under a platform-plus-products model anchored by its proprietary C-Mould technology and Syncura digital platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersOssett, United Kingdom
HQ citystring
Ossett
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision plastic moulding, medical device components, aerospace components manufacturing, pharmaceutical packaging components, drug delivery devices
Industry3 codes
1Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom)
CodeIMANAFACPrimaryYes
2Custom Injection Molding & Contract Manufacturing (Job Shops/CMs)
CodeIMANAFAJPrimaryNo
3Pharmaceutical & Medical Plastic Packaging Manufacturing
CodeIMANAEAKPrimaryNo
NAICS code1 code
  • Plastics Product Manufacturing3261
SIC code1 code
  • Plastics Products, Nec3089
Product category
Precision Plastic Components Manufacturing
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Syncura
Description

Digital platform for connected medical devices and health data solutions. Includes Syncura Series 1, 2, and 3 focusing on data insights and patient understanding.

carclo.co.uk
Core offering1 text field

Carclo plc manufactures fine-tolerance, injection-moulded plastic components for highly regulated markets across three divisions: Life Sciences (in vitro diagnostics, medical devices, drug delivery devices, pharmaceutical packaging), Aerospace & Defence (aerospace solutions, mechanical cable solutions), and Safety & Security (secure mechanisms, sensing optics, PPE, precision gear solutions). The company leverages proprietary C-Mould Technology for precision moulding and its Syncura digital platform for connected medical devices and respiratory drug delivery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Average customer relationship exceeds 15 years
+4 more records
Product overview1 text field

Carclo plc is a technical plastics manufacturer serving regulated markets in Life Sciences, Aerospace & Defence, and Safety & Security. The company operates a platform-plus-products model combining proprietary technologies (C-Mould Technology for precision moulding and Syncura digital platform for connected healthcare) with a comprehensive portfolio of precision-engineered plastic components. The Life Sciences division covers In Vitro Diagnostics & Medical Devices, Drug Delivery Devices, and Pharmaceutical Packaging. The Aerospace & Defence division provides Aerospace Solutions and Mechanical Cable Solutions. The Safety & Security division offers Secure Mechanisms, Sensing Optics, PPE, and Precision Gear Solutions. Carclo positions itself as a precision manufacturing partner with end-to-end capability from design and tooling to qualified production in-region.

Product and service12 records
1C-Mould Technology
CategoryManufacturing Technology Platform
Description

Proprietary moulding technology platform that enables precision engineered plastic components with validated quality at scale for regulated markets.

2Syncura
CategoryDigital Health Platform
Description

Connected healthcare digital platform for respiratory drug delivery and health data management, transforming raw health data into actionable patient understanding.

3In Vitro Diagnostics & Medical Devices
CategoryLife Sciences Components
Description

Precision plastic components for in vitro diagnostics and medical devices serving the life sciences market.

4Drug Delivery Devices
CategoryLife Sciences Components
Description

Engineered plastic components for drug delivery devices including respiratory drug delivery solutions.

5Pharmaceutical Packaging
CategoryLife Sciences Components
Description

Precision packaging solutions for pharmaceutical applications meeting regulated market requirements.

6Aerospace Solutions
CategoryAerospace & Defence Components
Description

Precision engineered components for aerospace applications where reliability is critical for flight safety.

7Mechanical Cable Solutions
CategoryAerospace & Defence Components
Description

Mechanical cable solutions for aerospace and defence applications requiring extreme performance and reliability.

8Secure Mechanisms
CategorySafety & Security Components
Description

Precision engineered secure mechanisms for safety and security applications including ATM components.

9Sensing Optics
CategorySafety & Security Components
Description

Optical sensing solutions for safety and security applications requiring precision engineered components.

10PPE (Personal Protective Equipment)
CategorySafety & Security Components
Description

Personal protective equipment solutions for the safety and security market segment.

11Precision Gear Solutions
CategorySafety & Security Components
Description

Precision gear solutions for safety-critical applications requiring exacting standards.

12Respiratory Drug Delivery
CategoryLife Sciences Components
Description

Connected respiratory drug delivery solutions leveraging the Syncura digital platform for patient monitoring.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based custom injection molder serving regulated medical, industrial, and specialty markets—overlaps with Carclo in custom/contract precision components at similar mid-market scale.

TypeDirect peer
Description

Precision injection molder for medical devices, diagnostics, and industrial components; comparable customer profile and qualification-driven selling motion to Carclo.

TypeEmerging player
Description

Custom plastic injection molder across consumer, medical, and industrial end-markets—an emerging competitor for Carclo's lower-end regulated and industrial volumes.

TypeDirect peer
Description

Medical and industrial precision injection molding including assemblies for diagnostics and drug delivery—a focused direct competitor to Carclo's Life Sciences vertical.

TypeDirect peer
Description

A Molex-owned precision plastic injection molding and contract manufacturer for medical devices, drug delivery, and diagnostics—directly overlapping with Carclo's Life Sciences core in IVD, drug delivery, and pharmaceutical packaging.

TypeDirect peer
Description

Specialty precision plastic molding and packaging for medical, pharmaceutical, and industrial markets; closest direct competitor to Carclo in regulated-mold injection components and pharma packaging.

TypeBroad incumbent
Description

Broader industrial incumbent in precision polymer and rubber seals/components for aerospace, medical, and industrial markets—wider portfolio but comparable precision engineering for regulated applications.

TypeEmerging player
Description

Specialty medical plastics and packaging provider serving OEMs with precision components in pharma, diagnostics, and devices—an emerging adjacent peer to Carclo's Life Sciences segment.

TypeDirect peer
Description

Specialty injection molder for medical, consumer, and industrial markets, overlapping Carclo's custom/contract molding capability for regulated customers.

10Nolte NCT (formerly GW Plastics)
TypeDirect peer
Description

Precision plastic injection molding serving medical device, diagnostics, and pharma customers with global manufacturing—directly comparable to Carclo's qualified, in-region production model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carclo plc

Precision Plastic Components Manufacturingcarclo.co.uk

Carclo plc is a UK-based precision plastics manufacturer supplying fine-tolerance injection-moulded components for regulated markets including life sciences (IVD, drug delivery, pharma packaging), aerospace and defence, and safety and security applications, operated under a platform-plus-products model anchored by its proprietary C-Mould technology and Syncura digital platform.

What Carclo plc does

Carclo plc is a UK-headquartered precision plastics manufacturer serving regulated end-markets across Life Sciences, Aerospace & Defence, and Safety & Security. Founded in 1924 and publicly traded on the London Stock Exchange (LON:CAR), the company specializes in fine-tolerance injection-moulded plastic components where regulatory qualification, traceability, and reliability are non-negotiable. Its Life Sciences segment supplies in vitro diagnostics, medical devices, drug delivery devices, and pharmaceutical packaging; Aerospace & Defence covers aerospace components and mechanical cable solutions; Safety & Security includes ATM secure mechanisms, sensing optics, PPE, and precision gear solutions.

The company operates a platform-plus-products model anchored by two proprietary technology assets: C-Mould, a precision moulding platform enabling validated production at scale, and Syncura, a digital platform for connected medical devices and patient health data. Syncura is being rolled out through a three-part series (launched March–May 2026) covering connected drug delivery, data-to-insight transformation, and an 'IQ vs AI' positioning piece. Production is structured as an end-to-end in-region capability spanning design, tooling, automated qualified manufacturing, and traceability, with facilities in the UK and India.

Carclo generates revenue through B2B contract-based pricing on engineered components, with go-to-market executed via direct enterprise relationships, trade-show presence (MD&M West, Pharmapack, DDL, MSV & Fakuma), and long-tenured customer partnerships averaging 15+ years. FY26 audited results reported revenue of £114.2m (down from £121m) with pre-tax profit of £4.8m; management has executed a 'margin before volume' portfolio simplification, reducing net debt leverage from 2.0x to 1.2x and tracking towards stated targets of 10% Return on Sales and 25% Return on Capital Employed under its Precision 2030 growth plan.

Carclo plc firmographics

Firmographics
Name
Carclo plc
Legal name
Carclo plc
Website
https://carclo.co.uk
Company type
Public
Founded year
1924
Operating status
Operating
Headcount range
251–500 employees
Short description
Carclo plc is a UK-based precision plastics manufacturer supplying fine-tolerance injection-moulded components for regulated markets including life sciences (IVD, drug delivery, pharma packaging), aerospace and defence, and safety and security applications, operated under a platform-plus-products model anchored by its proprietary C-Mould technology and Syncura digital platform.
Ownership category
akta.pro rank

Carclo plc industry classification

Industry
Product category
Precision Plastic Components Manufacturing
NAICS
Plastics Product Manufacturing (3261)
SIC
Plastics Products, Nec (3089)
akta.pro primary industry
Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom) (IMANAFAC)
akta.pro secondary industries
Custom Injection Molding & Contract Manufacturing (Job Shops/CMs) (IMANAFAJ), Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)

Keywords

  • Precision plastic moulding
  • Medical device components
  • Aerospace components manufacturing
  • Pharmaceutical packaging components
  • Drug delivery devices

Where Carclo plc is headquartered

Location

Headquarters

HQ city
Ossett
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Carclo plc business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Carclo plc product offering

Product offering

Core offering

Carclo plc manufactures fine-tolerance, injection-moulded plastic components for highly regulated markets across three divisions: Life Sciences (in vitro diagnostics, medical devices, drug delivery devices, pharmaceutical packaging), Aerospace & Defence (aerospace solutions, mechanical cable solutions), and Safety & Security (secure mechanisms, sensing optics, PPE, precision gear solutions). The company leverages proprietary C-Mould Technology for precision moulding and its Syncura digital platform for connected medical devices and respiratory drug delivery.

Product overview

Carclo plc is a technical plastics manufacturer serving regulated markets in Life Sciences, Aerospace & Defence, and Safety & Security. The company operates a platform-plus-products model combining proprietary technologies (C-Mould Technology for precision moulding and Syncura digital platform for connected healthcare) with a comprehensive portfolio of precision-engineered plastic components. The Life Sciences division covers In Vitro Diagnostics & Medical Devices, Drug Delivery Devices, and Pharmaceutical Packaging. The Aerospace & Defence division provides Aerospace Solutions and Mechanical Cable Solutions. The Safety & Security division offers Secure Mechanisms, Sensing Optics, PPE, and Precision Gear Solutions. Carclo positions itself as a precision manufacturing partner with end-to-end capability from design and tooling to qualified production in-region.

Differentiator

Problem solved

Functional benefit

Brands

  • Syncura: Digital platform for connected medical devices and health data solutions. Includes Syncura Series 1, 2, and 3 focusing on data insights and patient understanding.

Products and services

  • C-Mould Technology Proprietary moulding technology platform that enables precision engineered plastic components with validated quality at scale for regulated markets.
  • Syncura Connected healthcare digital platform for respiratory drug delivery and health data management, transforming raw health data into actionable patient understanding.
  • In Vitro Diagnostics & Medical Devices Precision plastic components for in vitro diagnostics and medical devices serving the life sciences market.
  • Drug Delivery Devices Engineered plastic components for drug delivery devices including respiratory drug delivery solutions.
  • Pharmaceutical Packaging Precision packaging solutions for pharmaceutical applications meeting regulated market requirements.
  • Aerospace Solutions Precision engineered components for aerospace applications where reliability is critical for flight safety.
  • Mechanical Cable Solutions Mechanical cable solutions for aerospace and defence applications requiring extreme performance and reliability.
  • Secure Mechanisms Precision engineered secure mechanisms for safety and security applications including ATM components.
  • Sensing Optics Optical sensing solutions for safety and security applications requiring precision engineered components.
  • PPE (Personal Protective Equipment) Personal protective equipment solutions for the safety and security market segment.
  • Precision Gear Solutions Precision gear solutions for safety-critical applications requiring exacting standards.
  • Respiratory Drug Delivery Connected respiratory drug delivery solutions leveraging the Syncura digital platform for patient monitoring.

Quantifiable outcome

  • Average customer relationship exceeds 15 years
  • +4 more outcomes

Companies that use Carclo plc

Customer profile

Segments3 records

Ideal customer profiles3 records

Carclo plc technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Carclo plc partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves5 records

Expansion highlights4 records

Carclo plc competitors and assessment

Company assessment

Direct peers

  • Mack Molding: US-based custom injection molder serving regulated medical, industrial, and specialty markets—overlaps with Carclo in custom/contract precision components at similar mid-market scale.
  • Tessy Plastics: Precision injection molder for medical devices, diagnostics, and industrial components; comparable customer profile and qualification-driven selling motion to Carclo.
  • Donatelle Plastics: Medical and industrial precision injection molding including assemblies for diagnostics and drug delivery—a focused direct competitor to Carclo's Life Sciences vertical.
  • Phillips Medisize: A Molex-owned precision plastic injection molding and contract manufacturer for medical devices, drug delivery, and diagnostics—directly overlapping with Carclo's Life Sciences core in IVD, drug delivery, and pharmaceutical packaging.
  • Spectrum Plastics Group: Specialty precision plastic molding and packaging for medical, pharmaceutical, and industrial markets; closest direct competitor to Carclo in regulated-mold injection components and pharma packaging.
  • MGS Manufacturing: Specialty injection molder for medical, consumer, and industrial markets, overlapping Carclo's custom/contract molding capability for regulated customers.
  • Nolte NCT (formerly GW Plastics): Precision plastic injection molding serving medical device, diagnostics, and pharma customers with global manufacturing—directly comparable to Carclo's qualified, in-region production model.

Emerging players

  • Evco Plastics: Custom plastic injection molder across consumer, medical, and industrial end-markets—an emerging competitor for Carclo's lower-end regulated and industrial volumes.
  • Medin Technologies (a Solesis company): Specialty medical plastics and packaging provider serving OEMs with precision components in pharma, diagnostics, and devices—an emerging adjacent peer to Carclo's Life Sciences segment.

Broad incumbents

  • Trelleborg Sealing Solutions: Broader industrial incumbent in precision polymer and rubber seals/components for aerospace, medical, and industrial markets—wider portfolio but comparable precision engineering for regulated applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Carclo plc social profiles

Digital presence

Carclo plc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carclo plc leadership team

Management profile

Number of profiles

Carclo plc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carclo plc M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carclo plc

What does Carclo plc do?

Carclo plc manufactures fine-tolerance, injection-moulded plastic components for highly regulated markets across three divisions: Life Sciences (in vitro diagnostics, medical devices, drug delivery devices, pharmaceutical packaging), Aerospace & Defence (aerospace solutions, mechanical cable solutions), and Safety & Security (secure mechanisms, sensing optics, PPE, precision gear solutions). The company leverages proprietary C-Mould Technology for precision moulding and its Syncura digital platform for connected medical devices and respiratory drug delivery.

Is Carclo plc a public or private company?

Carclo plc is a public company. It is classified as public and is currently operating.

When was Carclo plc founded?

Carclo plc was founded in 1924. It employs 251 to 500 people.

Where is Carclo plc based?

Carclo plc is headquartered in Ossett, United Kingdom, in the Europe region.

Who are Carclo plc's main competitors?

Direct peers on record are Mack Molding, Tessy Plastics, Donatelle Plastics, Phillips Medisize, Spectrum Plastics Group, MGS Manufacturing and Nolte NCT (formerly GW Plastics). Emerging players are Evco Plastics and Medin Technologies (a Solesis company). Trelleborg Sealing Solutions is listed as a broad incumbent.

Does Carclo plc have an API?

No public API is recorded for Carclo plc.

What industry is Carclo plc in?

Carclo plc's product category is Precision Plastic Components Manufacturing. Its primary akta.pro industry code is IMANAFAC, Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom), with a secondary code of IMANAFAJ, Custom Injection Molding & Contract Manufacturing (Job Shops/CMs). Its NAICS code is 3261 and its SIC code is 3089.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketsandMarketsJapan Medical Device Contract Manufacturing Market Size, Share,Trends, Growth Analysis Report, 2030The Japan medical device contract manufacturing market was valued at $990.4 million in 2025 and is projected to reach $1,449.7 million by 2030, growing at a compound annual growth rate of 7.9%. This expansion is driven by global OEMs seeking reliable partners with advanced capabilities in the Asia Pacific region. The report highlights key industry players including Carclo PLC, Nortech Systems, and Flex Ltd. among others.Investing.comCarclo announces format change for September AGM By Investing.comCarclo plc announced that its 2026 Annual General Meeting, scheduled for September 9 in Musselburgh, Scotland, will now include an audio-streamed option via the London Stock Exchange Sparklive platform alongside the traditional in-person gathering. Shareholders attending online are required to submit proxy votes by September 7 and cannot vote directly during the meeting. The physical venue, date, and time remain unchanged from previous announcements.Investing.comCarclo announces format change for September AGM By Investing.comCarclo plc announced that its 2026 Annual General Meeting, scheduled for September 9 in Musselburgh, Scotland, will include an audio-streamed option via the London Stock Exchange Sparklive platform alongside the traditional in-person gathering. Shareholders attending online are required to submit votes via proxy by September 7, as they cannot vote directly during the digital session. The company has also extended the deadline for shareholders to submit questions regarding AGM business to August 26.Investing.comCarclo achieves medium-term targets, sets 2030 growth plan By Investing.comCarclo plc reported trading results for the year ended March 31, 2026, achieving its medium-term Return on Sales and Return on Capital Employed targets one year ahead of schedule. Revenue is expected to reach approximately £114 million, down from £121 million in the prior year, while net debt increased to £24 million from £19.3 million. The company plans to announce its "Precision 2030" growth plan at its full year results presentation.GlobeNewswireForm 8.5 (EPT/RI) - Carclo plc (Amendment)Investec Bank plc, acting as exempt principal trader, disclosed dealings in Carclo plc ordinary shares on 2nd July 2018. The company purchased 32,010 shares at prices between 90 and 93.1 pence and sold 32,010 shares at prices between 98.8 and 100.5 pence.